Gencurix Inc (229000)

Currency in KRW
1,596
+29(+1.85%)
Closed·
229000 Scorecard
Full Analysis
Impressive gross profit margins
229000 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,5651,629
52 wk Range
1,1313,420
Key Statistics
Bid/Ask
1,596.00 / 1,606.00
Prev. Close
1,567
Open
1,567
Day's Range
1,565-1,629
52 wk Range
1,131-3,420
Volume
51.92K
Average Volume (3m)
287.23K
1-Year Change
-48.58%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
229000 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Gencurix Inc Company Profile

Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. The company was founded in 2011 and is headquartered in Seoul, South Korea.

Compare 229000 to Peers and Sector

Metrics to compare
229000
Peers
Sector
Relationship
P/E Ratio
−2.0x−1.9x−0.6x
PEG Ratio
−0.04−0.020.00
Price/Book
2.4x1.3x2.6x
Price / LTM Sales
7.4x2.4x3.3x
Upside (Analyst Target)
-50.2%37.4%
Fair Value Upside
Unlock6.0%4.5%Unlock

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-124.18 / --
Revenue / Forecast
1.44B / --
EPS Revisions
Last 90 days

229000 Income Statement

FAQ

What Stock Exchange Does Gencurix Trade On?

Gencurix is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Gencurix?

The stock symbol for Gencurix is "229000."

What Is the Gencurix Market Cap?

As of today, Gencurix market cap is 26.06B.

What Is Gencurix's Earnings Per Share (TTM)?

The Gencurix EPS (TTM) is -877.76.

From a Technical Analysis Perspective, Is 229000 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Gencurix Stock Split?

Gencurix has split 0 times.

How Many Employees Does Gencurix Have?

Gencurix has 0 employees.

What is the current trading status of Gencurix (229000)?

As of 25 Aug 2025, Gencurix (229000) is trading at a price of 1,596.00, with a previous close of 1,567.00. The stock has fluctuated within a day range of 1,565.00 to 1,629.00, while its 52-week range spans from 1,131.00 to 3,420.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.